Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene Therapy and Gene Editing for β-Thalassemia
Georgios E. Christakopoulos, Rahul Telange, Jonathan Yen, et al.
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 2, pp. 433-447
Open Access | Times Cited: 22

Showing 22 citing articles:

Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases
Mansoor Bolideei, Rambod Barzigar, Razieh Bahrami Gahrouei, et al.
Stem Cell Reviews and Reports (2025)
Closed Access | Times Cited: 1
Normal and dysregulated crosstalk between iron metabolism and erythropoiesis
Yelena Ginzburg, Xiuli An, Stefano Rivella, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 12
A retrospective analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation for transfusion-dependent β-thalassemia: focus on T and B lymphocyte reconstitution
Kaiqian Yang, Qianping Li, Xin Zhuang, et al.
Annals of Hematology (2025)
Closed Access
Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management
Joanne Traeger‐Synodinos, Christina Vrettou, Christalena Sofocleous, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3400-3400
Open Access | Times Cited: 3
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Sarkar Sardar Azeez, Rahin Shareef Hamad, Bahra Kakamin Hamad, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 3
C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies
Xing Zhang, Fangfang Xia, Xiaotian Zhang, et al.
Journal of Molecular Biology (2023) Vol. 436, Iss. 7, pp. 168343-168343
Open Access | Times Cited: 7
Gene editing withoutex vivoculture evades genotoxicity in human hematopoietic stem cells
Jing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Revolutionizing cattle breeding: Gene editing advancements for enhancing economic traits
Yuan Liu, Shuang Liu, Hui Sheng, et al.
Gene (2024) Vol. 927, pp. 148595-148595
Closed Access | Times Cited: 2
Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease
Michael D. Diamantidis, Georgia Ikonomou, Ioanna Argyrakouli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11886-11886
Open Access | Times Cited: 1
Interventions to reduce the risk the side-effects of cancer treatments in childhood
Bob Phillips, Jessica E. Morgan, Ruth Walker, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 11, pp. 1117-1129
Open Access | Times Cited: 1
Human cellular model systems of β-thalassemia enable in-depth analysis of disease phenotype
Deborah E. Daniels, Iván Ferrer-Vicens, Joseph Hawksworth, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Thalassemia Disorders: A Scoping Insight toward Management and Patient Care Prospects
Anmar Al‐Taie, Ammar Ürek, Hala Kayas, et al.
Journal of Preventive Diagnostic and Treatment Strategies in Medicine (2024) Vol. 3, Iss. 3, pp. 145-153
Closed Access
Gene Therapy in Hereditary Diseases
İlyas Yücel, Mahir Binici
Gene Therapy (2024), pp. 129-152
Closed Access
Revolutionizing animal husbandry: Breakthroughs in gene editing delivery systems
Yuan Liu, Xue Bai, Xue Feng, et al.
Gene (2024), pp. 149044-149044
Closed Access
Transamniotic Delivery of Hematopoietic Stem Cells Genetically Modified to Carry a Human Hemoglobin Subunit Beta Gene (HBB) in a Healthy Rodent Model
Kamila Moskowitzova, Emily M. Scire, Ina Kycia, et al.
Journal of Pediatric Surgery (2024), pp. 162120-162120
Closed Access
Cavitation is the determining mechanism for the atomization of high-viscosity liquid
Zhenzhen Gui, Yaohua Zeng, Tang Xie, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110071-110071
Open Access
Editorial: Editors’ showcase: red cells, iron and erythropoiesis
Anna Ritá Migliaccio
Frontiers in Hematology (2024) Vol. 3
Open Access
Gene Therapy: A Revolutionary Step in Treating Thalassemia
Malay Jhancy, R. Salama, Ghania Shehzad Alam Qureshi, et al.
Hematology Reports (2024) Vol. 16, Iss. 4, pp. 656-668
Open Access
Beta thalassemia syndromes: New insights
Ana Đordević, Ines Mrakovčić-Šutić, Sonja Pavlović, et al.
World Journal of Clinical Cases (2024) Vol. 13, Iss. 10
Closed Access
Reducing the transcriptional read‐through rate of a lentiviral vector for β‐thalassemia gene therapy
Jiahui Wu, Yuan Chen, Wenchen Shen, et al.
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Open Access
Editing of highly homologous gamma-globin genes by nickase deficient Base Editor mitigates large intergenic deletions
Anila George, Nithin Sam Ravi, B Vaishnavi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
When should gene therapy be considered for transfusion-dependent β-thalassemia patients?
Cheryl Mensah, Sujit Sheth
Hematology (2023) Vol. 2023, Iss. 1, pp. 121-124
Closed Access
Page 1

Scroll to top